Senior Director Medical Affairs Neuro-Rare

Lundbeck•Deerfield, IL

4d•Remote

About The Position

Do you want to join a team where the mission is meaningful, the challenges are complex, and you can directly see the results of your hard work? Lundbeck is a global biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases. Lundbeck employees are inspired and driven by our purpose to advance brain health and transform lives. Join us on our journey of growth! Remote Opportunity - Open to candidates anywhere in the United States SUMMARY: The Sr. Director, Medical Affairs Rare Neurology within US Medical Affairs will play a pivotal role reporting to the Vice President, Rare Neurology, US Medical Affairs. As a strategic partner and leader collaborating across research, development, and commercial functions, the Sr. Director ensures the alignment of Multiple System Atrophy (MSA) strategies with the needs of patients, healthcare professionals, payers and policy makers. This is an opportunity for a seasoned manager with rare neurology launch experience to lead a Medical Affairs team that delivers world-class engagement, practice-defining collaborations, and persuasive evidence.

Requirements

Doctoral Degree (PhD, PharmD, or MD.)
8+ years of experience which may include a combination of progressive medical/scientific affairs experience in the pharmaceutical, biotech, or related industry and relevant clinical or academia experience including at least 3 years leading medical strategy in industry
Managed full time direct reports for at least 2 years
Led the development and execution of integrated medical strategies
Directed medical affairs strategy, launch planning, evidence generation, and scientific communication initiatives to advance medical and corporate objectives
Led high-quality advisory boards and roundtables, ensuring capture of relevant and actionable insights
Oversaw the design and delivery of Medical Education programs (CME and non-CME) to enhance disease understanding and clinical engagement
Provided strategic oversight for evidence generation efforts, including study design, registries, real-world evidence initiatives, and publication planning
Served as senior medical reviewer for promotional or non-promotional materials, ensuring alignment with compliance standards and scientific accuracy
Championed the collection, synthesis, and application of scientific and clinical insights to inform strategic decision-making and cross-functional alignment
Recognized for strong scientific acumen, critical thinking, and the ability to drive data-driven, patient-centered strategies
Built and led high-performing teams, fostering a culture of collaboration, accountability, and innovation in a dynamic, fast-paced environment
Partnered effectively across global and regional teams to ensure alignment between medical, commercial, and regulatory priorities
Upheld the highest ethical standards, integrity, and professionalism in representing the organization to both internal and external stakeholders
Demonstrated track record of building strategic alliances with PAGs and patient families as research collaborators, ensuring patient perspectives shape scientific priorities
Highly proactive and solutions-oriented, capable of driving organizational progress in ambiguous or unstructured settings
Brings a mission-driven mindset — combining scientific rigor with empathy, credibility, and purpose to inspire cross-functional and external collaboration

Nice To Haves

Strong Preference to be based in Deerfield, IL Office
8+ years of non-field-based Medical Affairs experience in rare disease, experience preparing for and launching a rare neurology asset
5+ years managing a team of full-time direct reports
Demonstrated managerial success of a US Medical Affairs team through launch
Movement disorder specialist with established relationships within the movement disorder KOL and advocacy communities
Direct accountability for creating and managing a real-world rare disease registry partnership with KEEs
Direct accountability for phase IIIb/IV study design and execution for a rare disease
Past responsibility for managing IIT process
FDA regulatory knowledge and direct exposure

Responsibilities

Represent Lundbeck as a credible and knowledgeable scientific leader in the field of Movement Disorders, collaborate as a peer with external stakeholders to drive scientific leadership, improvement in diagnosis and access to treatment
Develop plans to achieve ambitious business objectives; execute aligned medical strategies and tactics with urgency and measurable impact
Shape evidence generation efforts to differentiate and expand access to treatment, working closely with global colleagues to support the design, protocol review and execution of Phase IIIb/IV studies, manage investigator-initiated (IIT) proposals
Lead and plan national advisory boards to inform and shape medical strategy
Develop and communicate high-quality medical content, compelling scientific narratives, engaging congress and field materials
Provide constructive input to optimize global publication strategy and represent US needs and priorities
Identify and create new opportunities to drive value for external stakeholders
Serve as medical reviewer and internal subject matter expert for promotional and nonpromotional materials
Provide medical perspectives to internal stakeholders (Commercial, Market Access, Regulatory, Clinical Development, Pharmacovigilance etc.) ensuring clinical and scientific alignment with integrated plans
Drive an ambitious external engagement agenda by identifying, developing and maintaining strong networks with key external stakeholders including investigators, thought leaders and healthcare practitioners; foster productive partnerships, engage through scientific congresses, and scientific exchange
Partner closely with Field Medical on overall strategy for external engagement, insights gathering and reporting, and translate insights to action
Remain intimately aware and abreast of evolving disease area trends and competitor activities to continuously anticipate changes and assess impact to US and Global scientific and brand strategy